Mrs Tammy M Ranney, PT - Medicare Physical Therapist in Sarasota, FL

Mrs Tammy M Ranney, PT is a medicare enrolled "Physical Therapist" provider in Sarasota, Florida. Her current practice location is 4776 Overbury Pl, Sarasota, Florida. You can reach out to her office (for appointments etc.) via phone at (941) 447-4171.

Mrs Tammy M Ranney is licensed to practice in Florida (license number PT21424) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1013945021.

Contact Information

Mrs Tammy M Ranney, PT
4776 Overbury Pl,
Sarasota, FL 34241-9227
(941) 447-4171
Not Available



Healthcare Provider's Profile

Full NameMrs Tammy M Ranney
GenderFemale
SpecialityPhysical Therapist
Location4776 Overbury Pl, Sarasota, Florida
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1013945021
  • Provider Enumeration Date: 06/29/2006
  • Last Update Date: 11/17/2022
  Medicare PECOS Information:
  • PECOS PAC ID: 7416924949
  • Enrollment ID: I20040914001018

Medical Identifiers

Medical identifiers for Mrs Tammy M Ranney such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1013945021NPI-NPPES
Y097UOtherFLBLUE CROSS & BLUE SHIELD
P00685897OtherFLRR MEDICARE

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
225100000XPhysical Therapist PT21424 (Florida)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Mrs Tammy M Ranney allows following entities to bill medicare on her behalf.
Provider NameWest Coast Therapy Specialist Llc
Provider TypePart B Supplier - Physical/occupational Therapy Group In Private Practice
Provider IdentifiersNPI Number: 1578810776
PECOS PAC ID: 0648549618
Enrollment ID: O20170706002356

News Archive

Nanoparticle-enabled peptide delivery triggers tumor regression

Cells possess a variety of ways of dealing with mutations that can cause them to grow uncontrollably and eventually form a tumor. The tumor suppressor gene p53 plays a critical role in these cancer prevention processes, largely by triggering a form a cell death known as apoptosis.

GHI won't compromise PEPFAR, Global AIDS Coordinator says at House Foreign Affairs' Committee hearing

During a House Committee on Foreign Affairs' hearing on the future of PEPFAR Wednesday, U.S. Global AIDS Coordinator Ambassador Eric Goosby assured lawmakers that the decision by President Barack Obama to make PEPFAR part of the president's Global Health Initiative (GHI) would not compromise "the widely praised plan," CQ HealthBeat reports.

PolyMedix presents data on PMX-60056 Phase 1B/2 studies for blood clotting at American Heart Association

PolyMedix, Inc, an emerging biotechnology company focused on developing new therapeutic drugs to treat life-threatening infectious diseases and acute cardiovascular disorders, announced that data from two Phase 1B/2 clinical studies with PMX-60056 were presented today, in oral and poster sessions, at the Annual American Heart Association Scientific Sessions Meeting. PMX-60056 is a synthetic, small-molecule designed to reverse the anti-clotting effects of both heparin and low molecule weight heparin (LMWH).

Race of donor may affect recurrent hepatitis C in patients after liver transplantation: Study

The race of liver donors may affect recurrent hepatitis C in patients after liver transplant, according to a study by Henry Ford Hospital. Patients receiving white cadaveric donor grafts had significantly more aggressive recurrent hepatitis C than those receiving grafts from African-American donors regardless of recipient race, says Matthew Moeller, M.D., gastroenterology fellow at Henry Ford Hospital and lead author of the study.

Tris announces FDA approval of first-ever ER chewable tablet

Tris Pharma, Inc. is pleased to announce that the U.S. Food and Drug Administration approved the first-ever extended-release (ER) chewable tablet, capping off a highly productive year with three Tris-developed NDAs approved in a calendar year.

Read more Medical News

› Verified 4 days ago

Provider NameNeighborhood Pt, Llc
Provider TypePart B Supplier - Physical/occupational Therapy Group In Private Practice
Provider IdentifiersNPI Number: 1457061699
PECOS PAC ID: 1456724798
Enrollment ID: O20230307001742

News Archive

Nanoparticle-enabled peptide delivery triggers tumor regression

Cells possess a variety of ways of dealing with mutations that can cause them to grow uncontrollably and eventually form a tumor. The tumor suppressor gene p53 plays a critical role in these cancer prevention processes, largely by triggering a form a cell death known as apoptosis.

GHI won't compromise PEPFAR, Global AIDS Coordinator says at House Foreign Affairs' Committee hearing

During a House Committee on Foreign Affairs' hearing on the future of PEPFAR Wednesday, U.S. Global AIDS Coordinator Ambassador Eric Goosby assured lawmakers that the decision by President Barack Obama to make PEPFAR part of the president's Global Health Initiative (GHI) would not compromise "the widely praised plan," CQ HealthBeat reports.

PolyMedix presents data on PMX-60056 Phase 1B/2 studies for blood clotting at American Heart Association

PolyMedix, Inc, an emerging biotechnology company focused on developing new therapeutic drugs to treat life-threatening infectious diseases and acute cardiovascular disorders, announced that data from two Phase 1B/2 clinical studies with PMX-60056 were presented today, in oral and poster sessions, at the Annual American Heart Association Scientific Sessions Meeting. PMX-60056 is a synthetic, small-molecule designed to reverse the anti-clotting effects of both heparin and low molecule weight heparin (LMWH).

Race of donor may affect recurrent hepatitis C in patients after liver transplantation: Study

The race of liver donors may affect recurrent hepatitis C in patients after liver transplant, according to a study by Henry Ford Hospital. Patients receiving white cadaveric donor grafts had significantly more aggressive recurrent hepatitis C than those receiving grafts from African-American donors regardless of recipient race, says Matthew Moeller, M.D., gastroenterology fellow at Henry Ford Hospital and lead author of the study.

Tris announces FDA approval of first-ever ER chewable tablet

Tris Pharma, Inc. is pleased to announce that the U.S. Food and Drug Administration approved the first-ever extended-release (ER) chewable tablet, capping off a highly productive year with three Tris-developed NDAs approved in a calendar year.

Read more Medical News

› Verified 4 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mrs Tammy M Ranney is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Mrs Tammy M Ranney, PT
4776 Overbury Pl,
Sarasota, FL 34241-9227

Ph: (941) 447-4171
Mrs Tammy M Ranney, PT
4776 Overbury Pl,
Sarasota, FL 34241-9227

Ph: (941) 447-4171

News Archive

Nanoparticle-enabled peptide delivery triggers tumor regression

Cells possess a variety of ways of dealing with mutations that can cause them to grow uncontrollably and eventually form a tumor. The tumor suppressor gene p53 plays a critical role in these cancer prevention processes, largely by triggering a form a cell death known as apoptosis.

GHI won't compromise PEPFAR, Global AIDS Coordinator says at House Foreign Affairs' Committee hearing

During a House Committee on Foreign Affairs' hearing on the future of PEPFAR Wednesday, U.S. Global AIDS Coordinator Ambassador Eric Goosby assured lawmakers that the decision by President Barack Obama to make PEPFAR part of the president's Global Health Initiative (GHI) would not compromise "the widely praised plan," CQ HealthBeat reports.

PolyMedix presents data on PMX-60056 Phase 1B/2 studies for blood clotting at American Heart Association

PolyMedix, Inc, an emerging biotechnology company focused on developing new therapeutic drugs to treat life-threatening infectious diseases and acute cardiovascular disorders, announced that data from two Phase 1B/2 clinical studies with PMX-60056 were presented today, in oral and poster sessions, at the Annual American Heart Association Scientific Sessions Meeting. PMX-60056 is a synthetic, small-molecule designed to reverse the anti-clotting effects of both heparin and low molecule weight heparin (LMWH).

Race of donor may affect recurrent hepatitis C in patients after liver transplantation: Study

The race of liver donors may affect recurrent hepatitis C in patients after liver transplant, according to a study by Henry Ford Hospital. Patients receiving white cadaveric donor grafts had significantly more aggressive recurrent hepatitis C than those receiving grafts from African-American donors regardless of recipient race, says Matthew Moeller, M.D., gastroenterology fellow at Henry Ford Hospital and lead author of the study.

Tris announces FDA approval of first-ever ER chewable tablet

Tris Pharma, Inc. is pleased to announce that the U.S. Food and Drug Administration approved the first-ever extended-release (ER) chewable tablet, capping off a highly productive year with three Tris-developed NDAs approved in a calendar year.

Read more News

› Verified 4 days ago


Physical Therapist in Sarasota, FL

The Weston Group Of Florida Inc
Physical Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 5311 Proctor Rd, Sarasota, FL 34233
Phone: 941-538-0950    
Active Life Therapy Services
Physical Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 4000 Sawyer Rd, Sarasota, FL 34233
Phone: 941-586-7110    Fax: 941-921-4820
Kevin Steele, DPT
Physical Therapist
Medicare: Accepting Medicare Assignments
Practice Location: 2055 Wood St Ste 110, Sarasota, FL 34237
Phone: 941-330-1677    Fax: 941-330-1688
Joyce Hegeman, PT
Physical Therapist
Medicare: Medicare Enrolled
Practice Location: 1959 N Honore Ave, Sarasota, FL 34235
Phone: 941-462-3980    Fax: 941-371-6827
Michael Ehlers, PT
Physical Therapist
Medicare: Accepting Medicare Assignments
Practice Location: 2750 Bahia Vista St, Sarasota, FL 34239
Phone: 941-951-2663    
Kyle Backofen, DPT
Physical Therapist
Medicare: Medicare Enrolled
Practice Location: 6150 N Lockwood Ridge Rd, Sarasota, FL 34243
Phone: 941-960-4741    
Melissa Guet, DPT
Physical Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 2401 University Pkwy Ste 103, Sarasota, FL 34243
Phone: 941-444-5970    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.